Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium

British Journal of Pharmacology

Volumn 123, Issue 7, 1998, Pages 1425-1433

  Morey, Timothy E ^a   Belardinelli, Luiz ^a   Dennis, Donn M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

A1 adenosine receptor; Adenosine; CCPA; Furchgott's method; R PIA; Receptor reserve

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 3 [3 [[4 (FLUOROSULFONYL)BENZOYL]OXY]PROPYL] 1 PROPYL XANTHINE; ADENOSINE A1 RECEPTOR; PHENYLISOPROPYLADENOSINE; RADIOLIGAND; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GUINEA PIG; HEART RIGHT ATRIUM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR AFFINITY;

ADENOSINE; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HEART ATRIA; MALE; METHODS; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0031937838     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701747     Document Type: Article

References (29)

1. ADAMS, J.U., PARONIS, C.A. & HOLTZMAN, S.G. (1990). Assessment of relative intrinsic activity of Mu-opioid analgesics in vitro by using β-funaltrexamine. J. Pharmacol. Exp. Ther., 225, 1027-1032.
2. 1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ. Res., 65, 1201-1211.
3. COLLIS, M.G. & HOURANI, S.M. (1993). Adenosine receptor subtypes. Trends Pharmacol. Sci., 14, 360-366.
4. DE LEON-CASASOLA, O.A. & LEMA, M.J. (1994). Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. Anesthesiology, 80, 303-309.
5. 1-adenosine receptors in guinea pig atrioventricular node. Am. J. Physiol., 262, H661-671.
6. DUTTAROY, A. & YOBURN, B.C. (1995). The effect of intrinsic efficacy on opioid tolerance. Anesthesiology, 82, 1226-1236.
7. EHLERT, F.J. (1987). Coupling of the muscarinic receptors to adenylate cyclase in the rabbit myocardium: effects of receptor inactivation. J. Pharmacol. Exp. Ther., 240, 23-30.
8. FURCHGOTT, R.F. (1966). The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in Drug Research. Vol. 3, ed Harper, N.J. & Simmonds, A.B. pp. 21-55. New York: Academic Press.
9. FURCHGOTT, R.F. & BURSZTYN, P. (1967). Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. New York Acad. Sci., 144, 882-899.
10. HARDEN, T.K., HENG, M. & BROWN, J.H. (1986). Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: Demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment. Mol. Pharmacol., 30, 200-206.
11. KENAKIN, T.P. & FERRIS, R.M. (1983). Effects on in vivo β-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol. J. Cardiovasc. Pharmacol., 5, 90-97.
12. KENAKIN, T. (1993). Pharmacological Analysis of Drug-Receptor Interaction. New York: Raven Press.
13. KENAKIN, T.P. (1984). The Classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev., 36, 165-222.
14. 1 adenosine receptors: persistent activation reveal spare receptors. Mol. Pharmacol., 30, 403-409.
15. LOHSE, M.J., UKENA, D. & SCHWABE, U. (1985). Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding. Naunyn-Schmeideberg's Arch. Pharmacol., 328, 310-316.
16. MAY, J.M., ABEL, P.W. & MINNEMAN, K.P. (1985). Binding of agonists and antagonists to β-adrenoceptors in rat vas deferens: relationship to functional response. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 324-333.
17. MELLER, E., BOHMAKER, K., NAMBA, Y., FRIEDHOFF, A.J. & GOLDSTEIN, M. (1987). Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol. Pharmacol., 31, 592-598.
18. 1A agonists. Mol. Pharmacol., 37, 231-237.
19. 1-adrenergic receptors and the potency of agonist in rat vas deferens. Mol. Pharmacol., 25, 56-63.
20. 1-adrenoceptor density and functional response of rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 238-246.
21. MJANGER, E. & YAKSH, T.L. (1991). Characteristics of dose-dependent antagonism by B-funaltrexamine of the antinociceptive effect of intrathecal mu agonists. J. Pharmacol. Exp. Ther., 258, 544-550.
22. MUSSER, B., MORGAN. M.E., LEID, M., MURRAY, T.F., LINDEN, J. & VESTRAL, R.E. (1993). Species comparison of adenosine and β-adrenoceptors in mammalian atrial and ventricular myocardium. Eur. J. Pharmacol., 246, 105-111.
23. 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex. J. Pharmacol. Exp. Ther., 32, 655-662.
24. PARONIS, C.A. & HOLTZMAN, S.G. (1992). Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther., 262, 1-9.
25. RAATIKAINEN, M.J.P., NAPOLITANO, C.A., DRUZGALA, P. & DENNIS, D.M. (1996). Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart. J. Pharmacol. Exp. Ther., 277, 1454-1463.
26. 1-adenosine receptor reserve for two actions of adenosinc on guinea pig atrial myocytes. Mol. Pharmacol., 52, 683-691.
27. 1-adenosine receptor. Mol. Pharmacol., 50, 196-205.
28. 2D-adrenergic receptor regulation G protein activation in PC12 cell membranes. Pharmacology, 52, 252-262.
29. ZERNIG, G., ISSAEVITCH, T., BROADBEAR, J.H., BURKE, T.F., LEWIS, J.W., BRINE, G.A. & WOODS, J.H. (1995). Receptor reserve and affinity of mu opioid agonists in mouse antinociception: Correlation with receptor binding. Life Sci., 57, 2113-2125.